Analysts Offer Insights on Healthcare Companies: PMV Pharmaceuticals (PMVP) and Phathom Pharmaceuticals (PHAT)

TipRanksMay 17 20:50

PMV Pharmaceuticals Initiated at Buy by Craig-Hallum

PMV Pharmaceuticals Initiated at Buy by Craig-Hallum

Dow JonesMay 14 00:30

Craig-Hallum Initiates Coverage On PMV Pharma With Buy Rating, Announces Price Target of $6

Craig-Hallum analyst Albert Lowe initiates coverage on PMV Pharma with a Buy rating and announces Price Target of $6.

Analyst UpgradesMay 14 00:20

PMV Pharma Q1 EPS $(0.30) Beats $(0.37) Estimate

PMV Pharma (NASDAQ:PMVP) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 28.57 percent increase over losses of $(0.42) p

BenzingaMay 9 20:52

PMV Pharmaceuticals | 10-Q: Quarterly report

Futu NewsMay 9 20:02 · Announcements

PMV Pharmaceuticals 1Q Loss/Shr 30c >PMVP

PMV Pharmaceuticals 1Q Loss/Shr 30c >PMVP

Dow JonesMay 9 20:00